Immune therapy for brain tumors: A new promising avenue

Glioblastoma is a particularly aggressive type of brain cancer. Only about one fifth of adults diagnosed with it survive two years or more after their diagnosis. Early clinical trial data show that a new two-drug combination might help people diagnosed with glioblastoma to fight the disease.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1mk1vYO